Medacta Launches Cobalt-Free SensiTiN Double Mobility Converter

Medacta SensiTiN Double Mobility Converter

First surgeries are complete in the U.S. with Medacta's cobalt-free SensiTiN Double Mobility Converter, following FDA clearance and positive EU market introduction in 2021.

Double Mobility devices are designed to address instability in primary and revision total hip replacement. To date, most of the Double Mobility Converters on the market are...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us